2012 - Medical Device Process Validation - Statistical Aspects - Webinar By GlobalCompliancePanel
Date2012-05-02
Deadline2012-05-02
VenueOnline Tra, USA - United States
Keywords
Websitehttp://bit.ly/J52phA
Topics/Call fo Papers
Overview: The FDA QSR requires device manufacturers to validate processes when the manufacturer cannot "fully verify the output". The manufacturer must validate these processes with a "high degree of assurance". The presentation explores the statistical underpinnings of these two phrases. To "fully verify the output" relates to the use of statistical sampling plans, while "high degree of precision" relates to process capability. The presentation illustrates the statistical concepts.
The presentation concludes by showing the strong relationship between validated processes and Risk Management. ISO 14971:2007 requires that production (and post-production) information go back to Risk Assessment to help complete the life cycle. Validated processes, where the manufacturer cannot fully verify the output, present a risk of product “escape”. Statistical information of each lot from a validated process should be part of the Risk Management File.
Why you should attend: If you conduct process validation, you need to ensure that your results are valid. Beyond the regulatory requirements, statistical approaches will help you achieve the desired result - processes that produce only conforming material. This is the essence of the statistical approach.This webinar presents the statistical approach that will help you validate your processes. Your team should attend this webinar if you cannot easily answer these questions.
Can you give the statistical rational for you verification sampling plans?
Can you state the desired and actual process capability you need to achieve?
Can you list the worst-case input parameter combination for your process?
Do you know how to determine challenge points for your process?
Have you set action limits for your process inputs?
Areas Covered In the Session:
QMS Requirements for Process Validation
FDA's QSR (21 CFR §820.75)
ISO 13485:2003
The Statistical Process Model
Relating input to output
The Process Output
Sampling Inspection
Process Capability
The Process Input Parameters
Design of Experiments
The Challenge Points
Risk Management
Production Information
Validated Processes as High Risk
Learning objectives:
Understand the QSR requirements for process validation
Explain the FDA’s approach as documented in Warning Letters
Understand the ISO 13485 requirements for process validation
State the statistical model that links process input and process output
Link sampling verification to the process model
Understand the role of process capability and describe the desired values of the indices
Understand the role of designed experiments in determining the input parameter space
Describe the role of challenge points in Operational Qualification
Recognize the role of process validation in Risk Management
Who will benefit:
Quality Managers
Quality Engineers
Production Managers
Production Supervisors
Manufacturing Engineers
Production Engineers
Design Engineers
Process Owners
Wednesday, May 2, 2012
10:00 AM PDT | 01:00 PM EDT
Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00
webinars-AT-globalcompliancepanel.com
http://www.globalcompliancepanel.com
Phone: 800-447-9407
Fax: 302-288-6884
The presentation concludes by showing the strong relationship between validated processes and Risk Management. ISO 14971:2007 requires that production (and post-production) information go back to Risk Assessment to help complete the life cycle. Validated processes, where the manufacturer cannot fully verify the output, present a risk of product “escape”. Statistical information of each lot from a validated process should be part of the Risk Management File.
Why you should attend: If you conduct process validation, you need to ensure that your results are valid. Beyond the regulatory requirements, statistical approaches will help you achieve the desired result - processes that produce only conforming material. This is the essence of the statistical approach.This webinar presents the statistical approach that will help you validate your processes. Your team should attend this webinar if you cannot easily answer these questions.
Can you give the statistical rational for you verification sampling plans?
Can you state the desired and actual process capability you need to achieve?
Can you list the worst-case input parameter combination for your process?
Do you know how to determine challenge points for your process?
Have you set action limits for your process inputs?
Areas Covered In the Session:
QMS Requirements for Process Validation
FDA's QSR (21 CFR §820.75)
ISO 13485:2003
The Statistical Process Model
Relating input to output
The Process Output
Sampling Inspection
Process Capability
The Process Input Parameters
Design of Experiments
The Challenge Points
Risk Management
Production Information
Validated Processes as High Risk
Learning objectives:
Understand the QSR requirements for process validation
Explain the FDA’s approach as documented in Warning Letters
Understand the ISO 13485 requirements for process validation
State the statistical model that links process input and process output
Link sampling verification to the process model
Understand the role of process capability and describe the desired values of the indices
Understand the role of designed experiments in determining the input parameter space
Describe the role of challenge points in Operational Qualification
Recognize the role of process validation in Risk Management
Who will benefit:
Quality Managers
Quality Engineers
Production Managers
Production Supervisors
Manufacturing Engineers
Production Engineers
Design Engineers
Process Owners
Wednesday, May 2, 2012
10:00 AM PDT | 01:00 PM EDT
Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00
webinars-AT-globalcompliancepanel.com
http://www.globalcompliancepanel.com
Phone: 800-447-9407
Fax: 302-288-6884
Other CFPs
Last modified: 2012-04-17 13:00:36